Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...
Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ...
Rheumatoid arthritis is an autoimmune condition that causes the body’s immune system to attack its own joints, leading to ...
An acupressure mat is one of the best home treatments that can help with back pain and injuries and provide you with ...
January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...
Certain vegan foods might help you manage autoimmune flare-ups—and some might make them worse. Here’s what you should know.
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
While GLP-1 therapies like Ozempic gain traction, personalized peptide therapies are supporting long-term health goals ...
Heck Capital Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, ...
Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 11,800 shares, a drop of 38.2% from the ...
A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.